Cantor Fitzgerald Has Lowered Expectations for Core Scientific (NASDAQ:CORZ) Stock Price

Core Scientific (NASDAQ:CORZ) had its price objective dropped by investment analysts at Cantor Fitzgerald from $26.00 to $25.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 57.83% from the stock’s previous close.

Several other equities research analysts have also weighed in on the stock. BTIG Research upgraded shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Tuesday, January 6th. Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 13th. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of Core Scientific in a research report on Tuesday. Keefe, Bruyette & Woods raised their price target on Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a report on Tuesday, January 27th. Finally, Sanford C. Bernstein boosted their price objective on Core Scientific from $17.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Core Scientific presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.84.

Core Scientific Price Performance

Shares of CORZ opened at $15.84 on Tuesday. The stock has a market capitalization of $4.99 billion, a PE ratio of 13.54 and a beta of 6.87. The business’s fifty day moving average price is $17.28 and its 200 day moving average price is $16.96. Core Scientific has a 12-month low of $6.20 and a 12-month high of $23.63.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.69. The business had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. During the same period last year, the company posted ($0.69) earnings per share. The firm’s revenue for the quarter was down 16.0% on a year-over-year basis. As a group, research analysts anticipate that Core Scientific will post 0.52 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Core Scientific

Several large investors have recently bought and sold shares of CORZ. Vanguard Group Inc. lifted its stake in shares of Core Scientific by 18.7% in the 4th quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock worth $494,462,000 after acquiring an additional 5,359,710 shares during the period. Situational Awareness LP increased its stake in shares of Core Scientific by 42.5% during the fourth quarter. Situational Awareness LP now owns 28,756,478 shares of the company’s stock valued at $418,694,000 after acquiring an additional 8,575,944 shares during the period. Jericho Capital Asset Management L.P. raised its holdings in Core Scientific by 11.4% during the fourth quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock worth $189,842,000 after purchasing an additional 1,338,796 shares in the last quarter. Value Aligned Research Advisors LLC bought a new stake in Core Scientific during the fourth quarter worth approximately $117,786,000. Finally, Geode Capital Management LLC lifted its position in Core Scientific by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 7,651,002 shares of the company’s stock worth $111,417,000 after purchasing an additional 109,145 shares during the period.

Key Headlines Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Multiple analyst upgrades/raises reinforce bullish expectations — Canaccord raised its target to $20 and kept a Buy rating, Needham upgraded to Buy with a $23 target, and HC Wainwright reaffirmed Buy at $25, signaling institutional conviction in the AI pivot and creating upside narrative for the stock. Canaccord Raise
• Positive Sentiment: Colocation (AI) revenue is accelerating — company reports show colocation revenue surged ~268% YoY, driven by contracts such as CoreWeave; that growth supports the strategic shift from Bitcoin mining toward higher-margin AI services. Colocation Revenue Surge
• Positive Sentiment: CoreWeave deal progressing ahead of schedule — management commentary and press pieces note the CoreWeave relationship is on track, supporting near-term colocation revenue visibility. CoreWeave Ahead of Schedule
• Positive Sentiment: Large call-option activity suggests speculative/bullish positioning — unusually high call volume (≈188,642 calls) indicates investors are placing leveraged bullish bets ahead of anticipated upside from the AI pivot.
• Neutral Sentiment: MarketBeat / analysis pieces argue a long-term, multi-billion backlog tied to AI colocation could unlock large upside, but these are thesis pieces rather than new company disclosures; useful for framing upside but dependent on execution. MarketBeat AI Thesis
• Neutral Sentiment: Short-interest entries in the feed show anomalous/zero values (likely reporting noise) and do not provide actionable short-seller signal at this time.
• Negative Sentiment: Top-line weakness and volatility in earnings — Q4 results showed a sharp revenue decline (reports cite ~38% YoY drop) and a revenue miss versus consensus, and management flagged negative adjusted EBITDA tied to the transition/expansion which pressured sentiment and drove intraday weakness after the release. Q4 Revenue Fall
• Negative Sentiment: Near-term sell-side caution and price action — media and market coverage noted a material stock pullback (one headline cited a ~14% drop after the pivot/earnings), reflecting investor concern about execution risk, cash burn for expansion, and balance-sheet pressure. Stock Drop After Pivot

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.